Safety Study of VAL-083 and Radiotherapy in Patients With Newly Diagnosed GBM Having Unmethylated MGMT Expression

NCT03050736 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioma
Glioblastoma
Glioblastoma Multiforme
GBM
Brain Cancer

Interventions

DRUG: VAL-083 (Dianhydrogalactitol)

Sponsor

Kintara Therapeutics, Inc.

Collaborators

[object Object]